Navigation Links
Virginia Interventional and Vascular Associates Offers Alternative to Hysterectomy for Uterine Fibroids
Date:4/22/2009

National OB-GYN Group States Uterine Artery Embolization 'Safe and Effective' for Appropriately Selected Patients

FREDERICKSBURG, Va., April 22 /PRNewswire/ -- Women with painful uterine fibroids are more likely to opt for a minimally invasive procedure over hysterectomy in the months ahead. That's the prediction of Virginia Interventional and Vascular Associates (VIVA) doctors following a bulletin on uterine artery embolization by The American College of Obstetricians and Gynecologists.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090421/NE02051 )

"Based on long- and short-term outcomes, uterine artery embolization is a safe and effective option for appropriately selected women who wish to retain their uteri," the practice bulletin reports. The bulletin, released in 2008, also evaluates other alternatives to hysterectomy.

Dr. R. Donald Doherty Jr. of VIVA, a group of interventional radiologists in Fredericksburg, VA, says their practice has performed uterine artery embolizations since 2001. The procedure, also known as uterine fibroid embolization (UFE), is offered primarily by interventional radiologists. Interventional radiologists apply their skills in reading medical images and performing minimally invasive procedures to diagnose and treat a variety of conditions.

"We applaud the ACOG for recognizing UFE as an effective alternative," Doherty says. "Many women have suffered from fibroids and have avoided surgical treatment because they are concerned about downtime from work, loss of income and other issues. The ACOG bulletin has opened the way for women to discuss with their OB-GYNs the treatment options that are available to them."

UFE is a minimally invasive procedure that blocks the blood supply to fibroids, causing them to shrink. It usually requires an overnight hospital stay. Most women resume light activities in a few days and the majority of women return to normal activities within seven to 10 days, according to the Society of Interventional Radiology. The society estimates that 85-90 percent of UFE patients experience significant or total improvement in pain and heavy bleeding caused by fibroids.

About VIVA

VIVA is part of Radiologic Associates of Fredericksburg. Its board-certified interventional radiologists are Dr. Michael P. McDermott, Dr. John J. McLaughlin, Dr. R. Donald Doherty Jr., and Dr. John D. Statler. VIVA doctors help diagnose and treat a variety of conditions, including uterine fibroids, spinal compression fractures, peripheral vascular disease, cancer, and varicose veins. For more information, call (540) 654-9118 or visit www.imagingway.com/ufe .


'/>"/>
SOURCE Virginia Interventional and Vascular Associates
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Virginia Tech Report Has National Importance
2. Virginia Tech Review Panel Calls For Reform of Mental Health Treatment Law
3. Patient Advocate Foundation Launches Program to Help Uninsured Virginians with Chronic, Debilitating and Life-Threatening Illness Access Quality Healthcare
4. Virginia Techs Raving First Year Results Lead to Additional High-Tech Antimicrobial Defense from SportCoatings(TM)
5. Thomson Healthcare Endorsed as Preferred Vendor of Information Products and Services for Virginia Hospitals
6. Virginia Faith Leaders Call on Senators Webb & Warner to Cosponsor Legislation to Protect Kids from Tobacco
7. Anthem Blue Cross and Blue Shield in Virginia Introduces New Generation of Consumer Driven Health Products
8. The Virginia G. Piper Charitable Trust and Flinn Foundation launch
9. Virginia G. Piper Charitable Trust and Flinn Foundation launch molecular diagnostics initiative
10. States Largest Medicaid Managed Care Plan Offering Training to Combat West Virginia Obesity Epidemic
11. Virginia Attorney General Addresses Drunk Driving and Underage Drinking in New Radio Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... Salt Lake City, Utah (PRWEB) , ... August 16, 2017 , ... ... its spot on the Inc 5000 list for the fourth consecutive year. ... the Inc. 5000 2017 list of the nation’s fastest growing companies. , ...
(Date:8/16/2017)... (PRWEB) , ... August 16, 2017 , ... ... to patients suffering from chronic pelvic pain. In addition to oncology services, ... pain disorders including endometriosis, menorrhagia (abnormal heavy bleeding during menstruation), uterine fibroids, and ...
(Date:8/16/2017)... ... August 16, 2017 , ... ... awards program which recognizes organizations that demonstrate the core values of business innovation, ... categories. , “As a global company, we are expanding our presence in all ...
(Date:8/16/2017)... ... , ... “Mom, God's Got This: Jamie's Story” is the creation of published author, Karen F. ... an insatiable appetite for God’s Word. , “I froze between the half walls, shelves on ... of oatmeal. I have one to this day on proud display in my dining room ...
(Date:8/15/2017)... ... ... city of Los Angeles is a west coast style fashion center as well as a ... website that spotlights fashion news from Los Angeles and around the world, is sharing clothing ... to the senior editor of latsl.com , “For a business that is known for ...
Breaking Medicine News(10 mins):
(Date:8/4/2017)... -- Agragen, LLC, a Cincinnati -based ... and aquacultural feed sectors, announces a significant step ... AGR131.  This drug is designed to trap and ... patients suffering from inflammatory conditions such as rheumatoid ... Biological pharmaceuticals currently used ...
(Date:8/2/2017)... BENTON, Ky. , Aug. 2, 2017   Marshall County Hospital in ... (ES) team to proactively reduce the risk of hospital-acquired infections (HAIs). The new addition, ... uses UVC light energy to kill deadly pathogens such as C. diff , MRSA, ... Tru-D SmartUVC ... Tru-D in action in a patient room ...
(Date:8/1/2017)... , Aug. 1, 2017   CerSci Therapeutics ... Dallas, Texas , has received notice from ... National Institutes of Health (NIH) that it has been ... grant totaling over $650,000 in 2017 with an additional ... CerSci,s Investigational New Drug application of their lead non-opioid ...
Breaking Medicine Technology: